Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionai
What To Know About The Ebola-Like Marburg Virus Amid False Alarm German Outbreak
There are no treatments or vaccines approved for Marburg, a virus in the same family as Ebola with a fatality rate between 24% to 88%.
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial
Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more rapid weight loss than its popular obesity injection Wegovy.
Valley Fever Outbreak: Dangerous Fungal Infection Linked To California Music Festival Grows
At least eight people have been hospitalized with valley fever—a potentially lethal fungal infection—after attending or working at a music festival in California, state health officials said.
Anthrax Outbreak In Wyoming Sparks Health Warning—Here’s What To Know
Wyoming’s last reported anthrax infection in wildlife was in 1956 and the state’s last confirmed cattle outbreak was in the 1970s.
Moderna’s First mRNA Mpox Vaccine Beats Licensed Rival Shots In Early Testing
The experimental mRNA shot, tested in macaques, generated a stronger immune response and dramatically reduced the number of mpox lesions in infected animals compared to Bavarian Nordic’s licensed vaccine, Jynneos.